<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PEN</journal-id>
<journal-id journal-id-type="hwp">sppen</journal-id>
<journal-id journal-id-type="nlm-ta">JPEN J Parenter Enteral Nutr</journal-id>
<journal-title>Journal of Parenteral and Enteral Nutrition</journal-title>
<issn pub-type="ppub">0148-6071</issn>
<issn pub-type="epub">1941-2444</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0148607112458325</article-id>
<article-id pub-id-type="publisher-id">10.1177_0148607112458325</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Communications</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Role of L-Arginine and Inducible Nitric Oxide Synthase in Intestinal Permeability and Bacterial Translocation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Quirino</surname><given-names>Iara Eliza Pacífico</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0148607112458325">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Cardoso</surname><given-names>Valbert Nascimento</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff2-0148607112458325">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Santos</surname><given-names>Rosana das Graças Carvalho dos</given-names></name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff1-0148607112458325">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Evangelista</surname><given-names>Warlley Pinheiro</given-names></name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff1-0148607112458325">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Arantes</surname><given-names>Rosa Maria Esteves</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff3-0148607112458325">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Fiúza</surname><given-names>Jacqueline Araújo</given-names></name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff4-0148607112458325">4</xref>
<xref ref-type="aff" rid="aff5-0148607112458325">5</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Glória</surname><given-names>Maria Beatriz Abreu</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0148607112458325">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Alvarez-Leite</surname><given-names>Jacqueline Isaura</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff6-0148607112458325">6</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Batista</surname><given-names>Marina Andrade</given-names></name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff7-0148607112458325">7</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Correia</surname><given-names>Maria Isabel Toulson Davisson</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff8-0148607112458325">8</xref>
</contrib>
</contrib-group>
<aff id="aff1-0148607112458325"><label>1</label>Departamento de Alimentos da Faculdade de Farmácia da Universidade Federal de Minas Gerais, Belo Horizonte, Brasil</aff>
<aff id="aff2-0148607112458325"><label>2</label>Departamento de Análises Clínicas e Toxicológicas da Faculdade de Farmácia da Universidade Federal de Minas Gerais, Belo Horizonte, Brasil</aff>
<aff id="aff3-0148607112458325"><label>3</label>Departamento de Patologia Geral do Instituto de Ciências Biológicas da Universidade Federal de Minas Gerais- Belo Horizonte, Brasil</aff>
<aff id="aff4-0148607112458325"><label>4</label>Centro de Pesquisa Renè Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brasil</aff>
<aff id="aff5-0148607112458325"><label>5</label>Departamento de Parasitologia do Instituto de Ciências Biológicas da Universidade Federal de Minas Gerais, Belo Horizonte, Brasil</aff>
<aff id="aff6-0148607112458325"><label>6</label>Departamento de Bioquímica e Imunologia do Instituto de Ciências Biológicas da Universidade Federal de Minas Gerais, Belo Horizonte, Brasil</aff>
<aff id="aff7-0148607112458325"><label>7</label>Departamento de Pediatria da Faculdade de Medicina da Universidade Federal de Minas Gerais, Belo Horizonte, Brasil</aff>
<aff id="aff8-0148607112458325"><label>8</label>Departamento de Cirurgia da Faculdade de Medicina da Universidade Federal de Minas Gerais, Belo Horizonte, Brasil</aff>
<author-notes>
<corresp id="corresp1-0148607112458325">Iara Eliza Pacífico Quirino, MD, Universidade Federal de Minas Gerais, Av. Presidente Antônio Carlos, 627 Campus Pampulha, Belo Horizonte, 31270-901, Brazil. Email: <email>iarapacifico@yahoo.com.br</email>.</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2013</year>
</pub-date>
<volume>37</volume>
<issue>3</issue>
<fpage>392</fpage>
<lpage>400</lpage>
<history>
<date date-type="received">
<day>4</day>
<month>1</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>7</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© 2012 American Society for Parenteral and Enteral Nutrition</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">The American Society for Parenteral and Enteral Nutrition</copyright-holder>
</permissions>
<abstract>
<p><italic>Background</italic>: Arginine has been shown to have several immunological and trophic properties in stressful diseases. Its metabolites, nitric oxide (NO) and polyamines, are related to arginine’s effects. Thus, the aim of this study was to determine the effects of the NO donor L-arginine and the role of inducible NO synthase (iNOS) on intestinal permeability and bacterial translocation in a model of intestinal obstruction (IO) induced by a simple knot in the terminal ileum. <italic>Material and Methods</italic>: Male C57BL6/J wild-type (WT) and iNOS knockout (iNOS–/–) mice were randomized into 6 groups: Sham and Sham–/– (standard chow), IO and IO–/– (standard chow +IO), and Arg and Arg–/– (standard chow supplemented with arginine + IO). After 7 days of treatment with standard or supplemented chows, IO was induced and intestinal permeability and bacterial translocation were evaluated. The small intestine and its contents were harvested for histopathological and morphometric analysis and the determination of polyamine concentration. <italic>Results</italic>: Pretreatment with arginine maintained intestinal permeability (<italic>P</italic> &gt; .05; Arg and Arg–/– groups vs Sham and Sham–/– groups), increased polyamine concentration in intestinal content (<italic>P</italic> &lt; .05; Arg vs IO group), and decreased bacterial translocation in WT animals (Arg group vs IO and IO–/– groups). Absence of iNOS also presented a protective effect on permeability but not on bacterial translocation. <italic>Conclusion</italic>: Arginine supplementation and synthesis of NO by iNOS are important factors in decreasing bacterial translocation. However, when intestinal permeability was considered, NO had a detrimental role.</p>
</abstract>
<kwd-group>
<kwd>arginine supplementation</kwd>
<kwd>nitric oxide knockout mice</kwd>
<kwd>polyamine</kwd>
<kwd>bacterial translocation</kwd>
<kwd>intestinal obstruction</kwd>
<kwd>intestinal permeability</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0148607112458325">
<title>Clinical Relevancy Statement</title>
<p>Arginine, a semi-essential amino acid, seems to be essential under stress situations. This amino acid has been shown to have several immunological and trophic effects. Thus, it was our goal to assess its role in an extremely severe intestinal obstruction model.</p>
</sec>
<sec id="section2-0148607112458325" sec-type="intro">
<title>Introduction</title>
<p>Arginine, a conditionally essential amino acid, has attracted great interest because of its numerous properties. Arginine stimulates the secretion of anabolic hormones, such as growth hormone, prolactin, and insulin-like growth factor 1, which may enhance protein synthesis and wound healing.<sup><xref ref-type="bibr" rid="bibr1-0148607112458325">1</xref></sup> Experimental studies have demonstrated that arginine influences cellular and humoral immunity, especially under catabolic conditions.<sup><xref ref-type="bibr" rid="bibr2-0148607112458325">2</xref>,<xref ref-type="bibr" rid="bibr3-0148607112458325">3</xref></sup></p>
<p>Arginine from dietary proteins is actively metabolized in enterocytes and supports several gut functions under stressful and inflammatory situations. In animal models of necrotizing enterocolitis, arginine has been reported to minimize intestinal damage. It plays a protective role in the intestinal mucosa under lipopolysaccharide endotoxemia conditions by increasing the enterocyte proliferation and preservation of microvilli.<sup><xref ref-type="bibr" rid="bibr4-0148607112458325">4</xref></sup> Moreover, arginine-enriched diets protect gut mucosa secondary to radiation-induced enteritis, which leads to decreased bacterial translocation.<sup><xref ref-type="bibr" rid="bibr5-0148607112458325">5</xref>,<xref ref-type="bibr" rid="bibr6-0148607112458325">6</xref></sup></p>
<graphic id="img1-0148607112458325" position="anchor" xlink:href="10.1177_0148607112458325-img1.tif"/>
<p>Many of these effects of arginine are attributed to its metabolites: nitric oxide (NO) and polyamines. NO is a small molecule synthesized from arginine by a family of NO synthases (NOSs)—endothelial and neuronal isoforms (eNOS and nNOS), which are continuously expressed, and the inducible isoform (iNOS), which is expressed in response to inflammatory stimuli, such cytokines and bacterial lipopolysaccharides.<sup><xref ref-type="bibr" rid="bibr7-0148607112458325">7</xref></sup> NO is an important intracellular and intercellular signaling molecule involved in the regulation of diverse physiological and pathophysiological mechanisms.<sup><xref ref-type="bibr" rid="bibr8-0148607112458325">8</xref></sup> Basal NO production maintains adequate perfusion, regulates intestinal permeability, and minimizes mucosal and microvascular barrier dysfunction after intestinal ischemia.<sup><xref ref-type="bibr" rid="bibr9-0148607112458325">9</xref>,<xref ref-type="bibr" rid="bibr10-0148607112458325">10</xref></sup> Although its biological effects are well established, the function of NO in sepsis and stressful conditions is controversial. The induction of iNOS by proinflammatory cytokines results in the enhanced formation of NO, which may contribute to hypotension and vascular hyporeactivity to vascular constrictors.<sup><xref ref-type="bibr" rid="bibr11-0148607112458325">11</xref></sup> A variety of experimental studies using iNOS knockout animals and selective and nonselective inhibitors have been developed to assess the function of NO under these conditions. Some demonstrated beneficial effects of inhibition of NOS; however, negative results have also been reported. Treatment of endotoxemic rats with selective iNOS inhibitors prevented acidosis, restored mean arterial pressure, and ameliorated gut mucosal barrier dysfunction.<sup><xref ref-type="bibr" rid="bibr12-0148607112458325">12</xref>,<xref ref-type="bibr" rid="bibr13-0148607112458325">13</xref></sup> In ischemia/reperfusion models, the selective inhibition of iNOS also showed positive effects, such as a decrease of edema and leukocyte rolling/ adhesion and attenuation of gut mucosal injury.<sup><xref ref-type="bibr" rid="bibr14-0148607112458325">14</xref><xref ref-type="bibr" rid="bibr15-0148607112458325"/>-<xref ref-type="bibr" rid="bibr16-0148607112458325">16</xref></sup> On the other hand, congenic iNOS knockout mice exhibited increased inflammation and mucosal injury under colitis conditions.<sup><xref ref-type="bibr" rid="bibr17-0148607112458325">17</xref>,<xref ref-type="bibr" rid="bibr18-0148607112458325">18</xref></sup> The nonselective inhibition of NOSs was associated with a decrease of mesenteric blood flow in colitis and sepsis models.<sup><xref ref-type="bibr" rid="bibr19-0148607112458325">19</xref>,<xref ref-type="bibr" rid="bibr20-0148607112458325">20</xref></sup> The discrepancy of these results may be explained by differences in experimental models, type, concentration, and timing of the injection of the inhibitor used.<sup><xref ref-type="bibr" rid="bibr21-0148607112458325">21</xref></sup></p>
<p>Polyamines are aliphatic molecules with amine groups distributed along their structure; they include putrescine, spermidine, and spermine. Endogenously, polyamines can be synthesized from ornithine by a reaction catalyzed by the enzyme ornithine decarboxylase. Arginine, in turn, may be converted into ornithine by arginase. There is evidence that polyamines are necessary for the growth and repair of gastrointestinal mucosa.<sup><xref ref-type="bibr" rid="bibr22-0148607112458325">22</xref></sup></p>
<p>Thus, the aim of the present study was to determine the effects of the NO donor, L-arginine, and iNOS using iNOS–/– mice to assess intestinal permeability, bacterial translocation, and intestinal polyamine synthesis in a model of IO. As a stressful stimulus, IO leads to inflammation, the infiltration of mononuclear cells, edema, and the synthesis of cytokines, inflammatory mediators, and NO; all of these contribute to increased intestinal permeability.<sup><xref ref-type="bibr" rid="bibr23-0148607112458325">23</xref></sup> To avoid the confounding effects and limitations of iNOS inhibitors, we used iNOS knockout mice to examine the effect of inducible NO synthesis.</p>
</sec>
<sec id="section3-0148607112458325" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="section4-0148607112458325">
<title>Animals</title>
<p>Male C57BL6/J WT and C57BL6/J iNOS –/– mice were provided by the Animal Care Unit of Instituto de Ciências Biológicas (ICB) of the Universidade Federal de Minas Gerais (UFMG). Mice 4–5 weeks old and weighing 16–20 g were used. All mice were housed individually in plastic boxes in a room with controlled light/dark cycle, temperature, and humidity. All procedures were in accordance with the Ethics Committee for Animal Experimentation at the UFMG and complied with the guidelines for the care and use of laboratory animals recommended by the Institute of Laboratory Animal Resources.</p>
</sec>
<sec id="section5-0148607112458325">
<title>Experimental Protocol</title>
<p>The animals were randomly divided into 6 groups: the <italic>Sham and Sham–/– groups</italic> (1, 2), which included C57BL6/J WT or C57BL6/J iNOS–/– mice fed standard chow and without intestinal obstruction (IO); the <italic>IO and IO–/– groups</italic> (3, 4), which included C57BL6/J WT or C57BL6/J iNOS–/– mice fed standard chow and given an IO; and the <italic>Arg and Arg–/– groups</italic> (5, 6), which included C57BL6/J WT or C57BL6/J iNOS–/– mice fed arginine-supplemented chow and given an IO. These groups received 100 mg of arginine daily. Conventional and supplemented chows were isocaloric and isoproteic. Water was provided ad libitum. The animals were fed these diets for 7 days prior to intestinal injury. Calorie, protein, nitrogen intake, and body weight were monitored and calculated from the daily consumption of conventional and supplemented chow. The following diagram shows the 6 groups:</p>
</sec>
<sec id="section6-0148607112458325">
<title>Preparation of the Supplemented Diet</title>
<p>Conventional chow was ground to a powder (74%) and added to arginine powder (3.5%), colorless gelatin powder (3.5%), corn starch (16%), soy oil (3%), and water. The starch and soy oil were added in these proportions to obtain isoproteic and isocaloric diets. Chow powder and arginine powder were homogenized with soy oil and dissolved gelatin in warm water. Extra water was added to guarantee homogenization. The homogenized diet mass was then divided in pellets. The pellets were dried in an oven at 45°C for 8 hours. Arginine is an amino acid that is stable in water solutions and is not destroyed by sterilizing processes or elevated temperatures.<sup><xref ref-type="bibr" rid="bibr24-0148607112458325">24</xref></sup> After drying, the pellets were weighed and given to the Arg and Arg–/– groups with the goal of supplying 100 mg arginine daily. The amount of supplemented chow that contained 100 mg arginine was calculated from the total preparation. This quantity of arginine corresponds to 3.5% of daily calorie intake. The supplemented diet was first offered to the animals in the morning, and only after they ingested all of it, regular chow was given ad libitum. By doing so, we guaranteed an intake of 100 mg arginine per day.<sup><xref ref-type="bibr" rid="bibr25-0148607112458325">25</xref></sup></p>
</sec>
<sec id="section7-0148607112458325">
<title>Surgical Procedure and Induction of IO</title>
<p>For 7 days, the Sham, Sham–/–, IO, and IO–/– groups received conventional chow ad libitum, whereas the Arg and Arg–/– groups received the diet supplemented with arginine. After 7 days, all the animals were anesthetized intraperitoneally with a xylazine (8.00 mg/kg) and ketamine (60.00 mg/kg) solution. The abdomen was opened through a midline incision, and the terminal ileum was isolated and ligated with a simple knot. Subsequently, the intestinal content was replaced, and the abdominal wound was closed in 2 layers. The Sham and Sham–/– groups only underwent the laparotomy. The IO (simple knot) was not performed in these groups. The terminal ileum was only manipulated outside the abdominal cavity and immediately replaced in it. The abdominal wound was closes in 2 layers.<sup><xref ref-type="bibr" rid="bibr25-0148607112458325">25</xref><xref ref-type="bibr" rid="bibr26-0148607112458325"/><xref ref-type="bibr" rid="bibr27-0148607112458325"/>-<xref ref-type="bibr" rid="bibr28-0148607112458325">28</xref></sup></p>
</sec>
<sec id="section8-0148607112458325">
<title>Intestinal Permeability</title>
<p>The animals were randomized into 6 groups of 15 animals each, as described above, to assess intestinal permeability. Each group was subdivided into 3 groups of 5 animals. Diethylenetriaminepentaacetic acid (DTPA) radiolabeled with of <sup>99m</sup>Technetium (<sup>99m</sup>Tc) was used to assess changes in intestinal permeability. DTPA is a macromolecule that rarely crosses the intestinal barrier. However, when intestinal permeability is increased as a result of intestinal mucosal injury, <sup>99m</sup>Tc-DTPA can be detected in the bloodstream.<sup><xref ref-type="bibr" rid="bibr29-0148607112458325">29</xref></sup> After 7 days of treatment, all mice received 0.1 mL <sup>99m</sup>Tc-DTPA by gavage. After 90 minutes, all mice underwent the previously described IO operation. This time between gavage with <sup>99m</sup>Tc-DTPA and operation corresponds to the time of gastric emptying. We have previously observed that after 90 minutes of gavage, <sup>99m</sup>Tc-DTPA left the stomach and reached the intestinal portion (data not presented).</p>
<p>Later, at 4, 8, and 18 hours, 5 animals from each group were anesthetized once more, and 500 µL blood was collected for radioactivity detection. Data are expressed as % dose, using the following equation:</p>
<p>% dose = cpm in blood/cpm of administrated dose × 100, where cpm is counts/min.<sup><xref ref-type="bibr" rid="bibr26-0148607112458325">26</xref><xref ref-type="bibr" rid="bibr27-0148607112458325"/>-<xref ref-type="bibr" rid="bibr28-0148607112458325">28</xref></sup></p>
</sec>
<sec id="section9-0148607112458325">
<title>Radiolabeling of <italic>Escherichia coli</italic> and Bacterial Translocation</title>
<p>A sample of <italic>Escherichia coli</italic> ATCC-10536 culture grown overnight in tryptic casein agar was transferred to 10 mL of sterile saline solution. A bacterial concentration of 10<sup>8</sup> CFU/mL was adjusted spectrophotometrically in 31% of transmittance at 580 nm. An aliquot of bacterial solution (2 mL) was incubated with 1 mL stannous chloride solution (580 mM, pH 7.0) at 37°C for 10 minutes. After incubation, 37.0 MBq <sup>99m</sup>Tc was added, and the solution was kept at 37°C for 10 minutes. The tubes were then centrifuged at 3000 <italic>g</italic> for 25 minutes, and 100 mL supernatant and 100 mL resuspended precipitate in saline were used to measure radioactivity. This procedure was repeated 3 times. The percent of <sup>99m</sup>Tc incorporated into the bacterial cells was determined using the following equation:</p>
<p>% labeled bacteria = cpm of precipitate/(cpm of precipitate + cpm of supernatant) × 100.<sup><xref ref-type="bibr" rid="bibr25-0148607112458325">25</xref><xref ref-type="bibr" rid="bibr26-0148607112458325"/><xref ref-type="bibr" rid="bibr27-0148607112458325"/>-<xref ref-type="bibr" rid="bibr28-0148607112458325">28</xref></sup></p>
<p>To assess bacterial translocation, the animals were randomized into 6 groups of 8 animals each, as described above. After 7 days of treatment, 0.1 mL suspension containing 1.8 MBq <italic>E coli</italic> radiolabeled with <sup>99m</sup>Technetium (<sup>99m</sup>Tc–<italic>E coli</italic>) was administered by gavage to all animals. After 90 minutes, the mice underwent surgical operations as previously described. This time between gavage with <sup>99m</sup>Tc–<italic>E coli</italic> and operation corresponds to the time of gastric emptying. We have previously observed that after 90 minutes of gavage, <sup>99m</sup>Tc–<italic>E coli</italic> left the stomach and reached the intestinal portion (data not presented).</p>
<p>Eighteen hours later, the animals were euthanized, and the blood, mesenteric lymph nodes (MLNs), liver, spleen, and lungs were removed and weighed for radioactivity detection. The samples were counted in a scintillation counter. The results are expressed as counts/min/g of tissue.<sup><xref ref-type="bibr" rid="bibr25-0148607112458325">25</xref><xref ref-type="bibr" rid="bibr26-0148607112458325"/><xref ref-type="bibr" rid="bibr27-0148607112458325"/>-<xref ref-type="bibr" rid="bibr28-0148607112458325">28</xref></sup></p>
</sec>
<sec id="section10-0148607112458325">
<title>Ileum Histology</title>
<p>Samples of the small bowel were taken for histological analysis 18 hours after surgery (n = 5 animals of each group). Mice were killed by cervical dislocation. A 1-cm ring of distal ileum adjacent and proximal to the IO was removed, immediately fixed in a 4% buffered formalin solution for 24 hours, and routinely processed for paraffin embedding. Briefly, tissue rings were dehydrated, cleared, embedded in paraffin, cut into sections 4 to 5 mm thick, stained by hematoxylin and eosin, and coded and analyzed by optical microscopy by a single pathologist who was unaware of the experimental conditions of each group.<sup><xref ref-type="bibr" rid="bibr26-0148607112458325">26</xref><xref ref-type="bibr" rid="bibr27-0148607112458325"/>-<xref ref-type="bibr" rid="bibr28-0148607112458325">28</xref></sup></p>
<graphic id="img2-0148607112458325" position="anchor" xlink:href="10.1177_0148607112458325-img2.tif"/>
<p>The edema was quantitatively scored by morphometry in 5 animals of each group by measuring the percentage of edematous area of the intestinal wall. Total and edema areas were measured (µm<sup>2</sup>) and the percentage of edematous area was calculated: % Edematous area = Edematous area (µm<sup>2</sup>) × 100/total area (µm<sup><xref ref-type="bibr" rid="bibr2-0148607112458325">2</xref></sup>). The program used was a KS 300 image analyzer (Carl Zeiss, Jena, Germany).</p>
</sec>
<sec id="section11-0148607112458325">
<title>Determination of Polyamines in Intestinal Fluid</title>
<p>The presence of putrescine, spermidine, and spermine was determined by high-performance liquid chromatography (HPLC). Briefly, 18 hours after surgery, the small intestine was removed. The contents were withdrawn, weighed, and suspended in phosphate-buffered saline (PBS; 500 mg intestinal content/2.0 mL PBS). After centrifugation at 2000 <italic>g</italic> for 30 minutes at 4°C, the supernatant was collected and kept frozen at −70°C until polyamine determination by HPLC<sup><xref ref-type="bibr" rid="bibr30-0148607112458325">30</xref></sup> (n = 5 animals of each group).</p>
</sec>
<sec id="section12-0148607112458325">
<title>Statistical Analysis</title>
<p>Weight; intake of calories, protein, and nitrogen; data from intestinal permeability, % edematous area, and concentration of polyamines in the intestinal fluid were compared using analysis of variance (ANOVA) tests, and a post hoc analysis was performed using Tukey’s test. The results are expressed as the mean ± standard deviation (SD). All these data were parametric. The bacterial translocation data were nonparametric, so they were analyzed using the Kruskal-Wallis ANOVA, and a post hoc analysis was performed using Dunn’s test. The results are expressed as median values.</p>
<p>Comparisons were performed between all groups simultaneity. Differences were considered statistically significant when <italic>P</italic> values were &lt;.05. All analyses were performed using the software GraphPad Prism 5 (GraphPad Software, La Jolla, CA).</p>
<p>The study design is summarized in the following diagram:</p>
</sec></sec>
<sec id="section13-0148607112458325" sec-type="results">
<title>Results</title>
<sec id="section14-0148607112458325">
<title>Weight Gain and Calorie, Protein, and Nitrogen Intake</title>
<p>There were no differences in mean weight gain or calorie, protein, or nitrogen intake among the groups (<xref ref-type="table" rid="table1-0148607112458325">Table 1</xref>).</p>
<table-wrap id="table1-0148607112458325" position="float">
<label>Table 1.</label>
<caption>
<p>Weight Gain and Calorie, Protein, and Nitrogen Intakes.</p></caption>
<graphic alternate-form-of="table1-0148607112458325" xlink:href="10.1177_0148607112458325-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Group</th>
<th align="center">Sham</th>
<th align="center">IO</th>
<th align="center">Arg</th>
<th align="center">Sham–/–</th>
<th align="center">IO–/–</th>
<th align="center">Arg–/–</th>
</tr>
</thead>
<tbody>
<tr>
<td>Weight gain, g</td>
<td>3.34 ± 0.95</td>
<td>3.36 ± 1.17</td>
<td>2.43 ± 0.87</td>
<td>2.88 ± 0.35</td>
<td>3.09 ± 0.59</td>
<td>2.56 ± 0.75</td>
</tr>
<tr>
<td>Caloric intake, kcal</td>
<td>10.65 ± 0.99</td>
<td>10.91 ± 1.40</td>
<td>11.53 ± 0.59</td>
<td>11.25 ± 0.56</td>
<td>11.10 ± 0.75</td>
<td>11.73 ± 0.71</td>
</tr>
<tr>
<td>Protein intake, g</td>
<td>0.74 ± 0.07</td>
<td>0.76 ± 0.10</td>
<td>0.80 ± 0.04</td>
<td>0.78 ± 0.05</td>
<td>0.77 ± 0.05</td>
<td>0.81 ± 0.05</td>
</tr>
<tr>
<td>Nitrogen intake, g</td>
<td>0.095 ± 0.009</td>
<td>0.097 ± 0.012</td>
<td>0.102 ± 0.005</td>
<td>0.100 ± 0.009</td>
<td>0.099 ± 0.007</td>
<td>0.104 ± 0.06</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0148607112458325">
<p>The data are expressed as the mean ± SD (n = 8 animals of each group). There were no differences between the groups (<italic>P</italic> &gt; .05). Arg, arginine; IO, intestinal obstruction.</p></fn>
</table-wrap-foot></table-wrap>
</sec>
<sec id="section15-0148607112458325">
<title>Intestinal Permeability</title>
<p><xref ref-type="fig" rid="fig1-0148607112458325">Figure 1</xref> shows the data for intestinal permeability at 4, 8, and 18 hours after IO. The Sham, Sham–/–, and Arg groups did not present with significant permeability changes (<italic>P</italic> ≥ .05). The IO–/– and Arg–/– groups showed increases in intestinal permeability. In the IO–/– group, significant increase began at 4 hours and remained constant until 8 hours. In the Arg–/– group, intestinal permeability was enhanced through 8 hours but not significantly. By 18 hours, permeability in IO–/– and Arg–/– groups decreased to values similar to those observed in the Sham, Sham–/–, and Arg groups at 18 hours. Finally, the intestinal permeability of the IO group increased significantly at 4, 8, and 18 hours after IO.</p>
<fig id="fig1-0148607112458325" position="float">
<label>Figure 1.</label>
<caption>
<p>Intestinal permeability at 4, 8, and 18 hours after inducing intestinal obstruction (IO). Data are expressed as the mean % dose injected ± SD (n = 5 animals of each group). Comparisons were performed between the groups. Different letters at each time point indicate significant differences. Arg, arginine.</p>
</caption>
<graphic xlink:href="10.1177_0148607112458325-fig1.tif"/></fig>
</sec>
<sec id="section16-0148607112458325">
<title>Ileum Histology</title>
<p>The Sham and Sham–/– groups did not present with significant morphological alterations and were not significantly different from one another (<xref ref-type="fig" rid="fig2-0148607112458325">Figure 2A</xref>,<xref ref-type="fig" rid="fig2-0148607112458325">B</xref>). The IO and IO–/– groups presented with changes in intestinal wall integrity, primarily in the area surrounding the intestinal obstruction. Inflammation, edema, and an increase in the number of polymorphonuclear cells were observed in this area. In most animals of the IO group, there were signs of necrosis in the intestinal wall. The IO–/– group exhibited better integrity of intestinal wall when compared with the IO group, and this was shown by qualitative aspects in <xref ref-type="fig" rid="fig2-0148607112458325">Figure 2C</xref>,<xref ref-type="fig" rid="fig2-0148607112458325">D</xref>. Pretreatment with arginine partially protected the intestinal wall. The Arg and Arg–/– groups had increased regeneration and decreased inflammation as well as congestion of the submucosal and muscular layers. On the other hand, edema and congestion were more visible in the Arg–/– group (<xref ref-type="fig" rid="fig2-0148607112458325">Figure 2E</xref>,<xref ref-type="fig" rid="fig2-0148607112458325">F</xref>).</p>
<fig id="fig2-0148607112458325" position="float">
<label>Figure 2.</label>
<caption>
<p>Histopathological aspects of the ileum wall of wild-type (WT) and inducible nitric oxide synthase (iNOS)–/– mice. Sham and Sham–/– groups did not present with significant morphological alterations (A and B). Intestinal obstruction (IO) and IO–/– groups (C and D) showing edema (thin arrows). In the IO–/– group (D), there was better integrity of the epithelial layer. Arginine (Arg) and Arg –/– groups (E and F) showing partial protection associated with increased regenerative epithelial changes. The vascular changes (edema and congestion, F, arrows) were more visible in the Arg –/– group (n = 5 animals of each group).</p></caption>
<graphic xlink:href="10.1177_0148607112458325-fig2.tif"/></fig>
<p>The edema is representative of vascular changes affecting the intestinal wall and was significantly increased in IO and IO–/– groups when compared with all others (<xref ref-type="table" rid="table2-0148607112458325">Table 2</xref>). On the other hand, the edematous area was significantly decreased in Sham and Sham–/– groups, as well as in Arg and Arg–/– groups. The morphometric analysis confirms our histological qualitative interpretation as shown in <xref ref-type="fig" rid="fig2-0148607112458325">Figure 2</xref>.</p>
<table-wrap id="table2-0148607112458325" position="float">
<label>Table 2.</label>
<caption>
<p>Percentage of Edematous Area.</p></caption>
<graphic alternate-form-of="table2-0148607112458325" xlink:href="10.1177_0148607112458325-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Group</th>
<th align="center">Sham</th>
<th align="center">IO</th>
<th align="center">Arg</th>
<th align="center">Sham–/–</th>
<th align="center">IO–/–</th>
<th align="center">Arg–/–</th>
</tr>
</thead>
<tbody>
<tr>
<td>% edematous area</td>
<td>3.17 ± 0.35<sup>a</sup></td>
<td>39.12 ± 3.21<sup>e</sup></td>
<td>10.04 ± 2.37<sup>b</sup></td>
<td>4.16 ± 1.30<sup>a</sup></td>
<td>33.63 ± 3.78<sup>d</sup></td>
<td>18.66 ± 2.14<sup>c</sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0148607112458325"><p>The data are expressed as the mean ± SD (n = 5 animals of each group). Simultaneous comparison was performed between the different groups of treatments. Different letters represent significant differences (<italic>P</italic> &lt; .05). Arg, arginine; IO, intestinal obstruction.</p></fn>
</table-wrap-foot></table-wrap>
</sec>
<sec id="section17-0148607112458325">
<title>Polyamines in Intestinal Fluid</title>
<p>Putrescine was not identified in any group. There was an increase in the spermidine and spermine levels in the Arg and Arg–/– groups, but the Sham and Sham–/– groups showed the highest levels of polyamines in their intestinal fluid (<xref ref-type="fig" rid="fig3-0148607112458325">Figures 3</xref> and <xref ref-type="fig" rid="fig4-0148607112458325">4</xref>).</p>
<fig id="fig3-0148607112458325" position="float">
<label>Figure 3.</label>
<caption>
<p>Spermidine concentrations. The data are expressed as the means ± SD (n = 5 animals of each group). Simultaneous comparison was performed between the different groups of treatments. Different letters represent significant differences (<italic>P</italic> &lt; .05). Arg, arginine; IO, intestinal obstruction.</p>
</caption>
<graphic xlink:href="10.1177_0148607112458325-fig3.tif"/></fig>
<fig id="fig4-0148607112458325" position="float">
<label>Figure 4.</label>
<caption>
<p>Spermine concentrations. The data are expressed as the means ± SD (n = 5 animals of each group). Simultaneous comparison was performed between the different groups of treatments. Different letters represent significant differences (<italic>P</italic> &lt; .05). Arg, arginine; IO, intestinal obstruction.</p>
</caption>
<graphic xlink:href="10.1177_0148607112458325-fig4.tif"/></fig>
</sec>
<sec id="section18-0148607112458325">
<title>Bacterial Translocation</title>
<p>The uptake of <sup>99m</sup>Tc–<italic>E coli</italic> by blood, MLN, liver, spleen, and lungs was significantly higher in the IO, Sham–/–, IO–/–, and Arg–/– groups (<italic>P</italic> &lt; .05). There was no difference between the Sham and Arg groups (<italic>P</italic> ≥ .05) (<xref ref-type="table" rid="table3-0148607112458325">Table 3</xref>).</p>
<table-wrap id="table3-0148607112458325" position="float">
<label>Table 3.</label>
<caption>
<p>Biodistribution of <sup>99m-Tc</sup><italic>Escherichia coli</italic> (cpm/g).</p></caption>
<graphic alternate-form-of="table3-0148607112458325" xlink:href="10.1177_0148607112458325-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Sham</th>
<th align="center">IO</th>
<th align="center">Arg</th>
<th align="center">Sham–/–</th>
<th align="center">IO–/–</th>
<th align="center">Arg–/–</th>
</tr>
</thead>
<tbody>
<tr>
<td>MLN</td>
<td>104.35<sup>a</sup></td>
<td>2271.43<sup>b</sup></td>
<td>292.22<sup>a</sup></td>
<td>2169.01<sup>b</sup></td>
<td>2642.86<sup>b</sup></td>
<td>2937.50<sup>b</sup></td>
</tr>
<tr>
<td>Blood</td>
<td>58.33<sup>a</sup></td>
<td>450.72<sup>b</sup></td>
<td>93.08<sup>a</sup></td>
<td>234.29<sup>b</sup></td>
<td>778.00<sup>b</sup></td>
<td>409.38<sup>b</sup></td>
</tr>
<tr>
<td>Liver</td>
<td>239.11<sup>a</sup></td>
<td>817.27<sup>b</sup></td>
<td>298.21<sup>a</sup></td>
<td>500.78<sup>b</sup></td>
<td>1137.78<sup>b</sup></td>
<td>793.16<sup>b</sup></td>
</tr>
<tr>
<td>Lung</td>
<td>213.17<sup>a</sup></td>
<td>1407.27<sup>b</sup></td>
<td>163.21<sup>a</sup></td>
<td>1098.90<sup>b</sup></td>
<td>1033.99<sup>b</sup></td>
<td>898.93<sup>b</sup></td>
</tr>
<tr>
<td>Spleen</td>
<td>136.02<sup>a</sup></td>
<td>1268.03<sup>b</sup></td>
<td>335.00<sup>a</sup></td>
<td>1057.69<sup>b</sup></td>
<td>1976.74<sup>b</sup></td>
<td>702.25<sup>b</sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0148607112458325"><p>The data are expressed as the median (n = 8 animals of each group). Simultaneous comparison was performed between the different groups of treatments. Different letters represent significant differences (<italic>P</italic> &lt; .05). Arg, arginine; cpm, counts per minute; IO, intestinal obstruction; MLN, mesenteric lymph nodes.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="section19-0148607112458325" sec-type="discussion">
<title>Discussion</title>
<p>Arginine has been postulated to become essential during catabolic conditions such as wound healing, protein anabolism, and the immunological response. Both animal and human studies have demonstrated a reduction in plasma and/or muscle levels of arginine under sepsis and stressful situations.<sup><xref ref-type="bibr" rid="bibr31-0148607112458325">31</xref>,<xref ref-type="bibr" rid="bibr32-0148607112458325">32</xref></sup> The balance between endogenous production and consumption of arginine by NOS and arginase is profoundly disturbed during these conditions.<sup><xref ref-type="bibr" rid="bibr31-0148607112458325">31</xref></sup> Therefore, the role of arginine supplementation and NOS on bacterial translocation and intestinal permeability was evaluated in this experimental study.</p>
<p>The intestinal epithelium acts as a protective barrier against macromolecules and microorganisms.<sup><xref ref-type="bibr" rid="bibr33-0148607112458325">33</xref></sup> Under pathologic conditions such as shock, trauma, or surgical stress, it becomes especially vulnerable, which can lead to increased permeability, bacterial translocation, and the release of endotoxins into the systemic circulation.<sup><xref ref-type="bibr" rid="bibr34-0148607112458325">34</xref></sup></p>
<p>The Sham and Sham–/– groups did not present with significant morphological alterations of the ileum. However, these groups presented with low bacteria counts at all of the investigated sites. These results indicate that bacterial translocation may be a normal physiological event without deleterious consequences. Translocation of endotoxins from viable or dead bacteria in very small amounts probably constitutes a physiologically important boost to the reticuloendothelial system, especially to the Kupffer cells in the liver.<sup><xref ref-type="bibr" rid="bibr33-0148607112458325">33</xref></sup></p>
<p>On the other hand, the IO and IO–/– groups exhibited increased intestinal permeability. Changes in all layers of the intestinal wall, primarily in the area where the IO was induced, were observed. IO impedes gut vascularization, and a reduction in blood flow may decrease tissue oxygenation, leading to mucosal acidosis, epithelial cell injury, and alterations of mucosa cytoskeleton and the epithelial cells junction. The final result is an increase in mucosal permeability.<sup><xref ref-type="bibr" rid="bibr33-0148607112458325">33</xref>,<xref ref-type="bibr" rid="bibr35-0148607112458325">35</xref></sup> A third element may be associated with increased intestinal permeability in the IO group. The induction of iNOS by inflammatory processes produces NO continually and in large concentrations. NO overproduction may lead to decreased endothelial viability and may contribute to tissue damage through both direct cytotoxic effects and the interaction with reactive oxygen intermediates.<sup><xref ref-type="bibr" rid="bibr36-0148607112458325">36</xref>,<xref ref-type="bibr" rid="bibr37-0148607112458325">37</xref></sup> This hypothesis may explain the less severe alterations in permeability observed in the IO–/– group. This group had increased intestinal permeability up to 8 hours, but at 18 hours, improvement of intestinal permeability was observed.</p>
<p>Intestinal permeability remained unchanged in wild-type animals that received arginine supplementation (Arg group). In the Arg–/– group, significantly increased intestinal permeability was observed 8 hours after the IO, but the permeability values later returned to baseline. It is well established that arginine may improve mucosal morphometric aspects and increase enterocyte proliferation and the number and height of villi under stress situations such as trauma, ischemia, intestinal resection, or obstruction.<sup><xref ref-type="bibr" rid="bibr5-0148607112458325">5</xref>,<xref ref-type="bibr" rid="bibr28-0148607112458325">28</xref>,<xref ref-type="bibr" rid="bibr38-0148607112458325">38</xref><xref ref-type="bibr" rid="bibr39-0148607112458325"/>-<xref ref-type="bibr" rid="bibr40-0148607112458325">40</xref></sup> Pretreatment with arginine ameliorated inflammation, epithelial reactivity and mucin depletion in iNOS–/– mice.<sup><xref ref-type="bibr" rid="bibr41-0148607112458325">41</xref></sup> In our study, arginine supplementation partially protected the intestinal mucosa. The Arg and Arg–/– groups presented with signs of epithelial injury, which were expected due to the IO (knot) induced in these groups. Inflammation and congestion of the submucosal layer were reduced when compared with the IO and IO–/– groups. The trophic effects of arginine can be explained by the increase of secretion of polyamines via arginase.<sup><xref ref-type="bibr" rid="bibr24-0148607112458325">24</xref>,<xref ref-type="bibr" rid="bibr42-0148607112458325">42</xref></sup> Polyamines have been shown to have numerous relevant biological effects, including stimulation of epithelial restitution by enhancing cell migration and proliferation and the regulation of apoptosis.<sup><xref ref-type="bibr" rid="bibr43-0148607112458325">43</xref></sup> In our study, mice that received arginine had higher levels of spermine and spermidine in the intestinal fluid. These findings may be attributable to enhanced arginine available in the substrate for polyamine synthesis via arginase in the arginine groups. The supplementation of polyamine precursors is related to increased levels of intestinal polyamines and the height of the villi mucosa after resection.<sup><xref ref-type="bibr" rid="bibr44-0148607112458325">44</xref></sup> In a model of sepsis and intestinal ischemia, the supply of polyamine precursors accelerated the repair of intestinal mucosal.<sup><xref ref-type="bibr" rid="bibr45-0148607112458325">45</xref>,<xref ref-type="bibr" rid="bibr46-0148607112458325">46</xref></sup> We observed similar results in our study. After 8 hours of IO, the Arg–/– group exhibited recovery of the intestinal permeability.</p>
<p>Pretreatment with arginine in wild-type mice reduced bacterial translocation. Previous studies from our group also indicated that arginine can reduce bacterial translocation in Swiss mice and Wistar rats in models of IO.<sup><xref ref-type="bibr" rid="bibr25-0148607112458325">25</xref>,<xref ref-type="bibr" rid="bibr28-0148607112458325">28</xref></sup> The role of arginine in decreasing bacterial translocation may be linked to an improvement or modulation of immunologic parameters, primarily innate immunity.<sup><xref ref-type="bibr" rid="bibr39-0148607112458325">39</xref>,<xref ref-type="bibr" rid="bibr47-0148607112458325">47</xref></sup> Moreover, arginine is the sole physiologic source of nitrogen for NO synthesis. This molecule is toxic to many pathogens and is a crucial component of the innate immune response.<sup><xref ref-type="bibr" rid="bibr48-0148607112458325">48</xref></sup> Interestingly, the IO–/– and Arg–/– groups presented with significantly increased bacterial translocation despite maintaining or recovering intestinal permeability. Therefore, this event may not be associated with increased permeability. Current data suggest 2 major pathways of gastrointestinal impairment that might cause translocation: transcellular through enterocytes or paracellular through tight junctions. Nevertheless, translocation generally occurs transcellularly and directly, even through morphologically intact enterocytes. Transcellular passage is under the control of specific enterocyte channels and membrane pumps. Experimental evidence demonstrates the presence of viable bacteria, including <italic>E coli</italic>, within the intact enterocytes of rats, which indicates the occurrence of transcellular passage through pinocytosis and active bacteria invasion of the mucosa barrier.<sup><xref ref-type="bibr" rid="bibr33-0148607112458325">33</xref></sup> Another factor involved in increased bacterial translocation in these groups is the absence of iNOS, which would impair the antibacterial host. In the Arg–/– group, the positive effects of arginine in decreasing bacterial translocation may have been disguised by the absence of NO synthesized by iNOS.</p>
</sec>
<sec id="section20-0148607112458325" sec-type="conclusions">
<title>Conclusions</title>
<p>This study shows that arginine supplementation and synthesis of NO by iNOS are important factors in decreasing bacterial translocation in an IO model. However, when intestinal permeability is considered, NO appears to have a detrimental role. Thus, further investigations into the immunologic role of arginine and NO are necessary to better clarify the observed results.</p>
</sec>
</body>
<back>
<ack><p>We thank the Pró-Reitoria de Pesquisa da Universidade Federal de Minas Gerais for support by reviewing this manuscript and the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Fapemig (Fundação de Amparo à Pesquisa do Estado de Minas Gerais) for financial support.</p></ack>
<fn-group>
<fn fn-type="financial-disclosure">
<p>Financial disclosure: This work was partially funded by CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico) and Fapemig (Fundação de Amparo à Pesquisa do Estado de Minas Gerais), Brazil. IEPQ, RGCS, WPE, and MAB received a scholarship from CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico). RMEA, MBAG, JIA-L, VNC, and MITDC received research fellowships from Conselho Nacional de Pesquisa (CNPq).</p>
</fn>
<fn fn-type="other">
<p>This article originally appeared online on August 22, 2012.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0148607112458325">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fan</surname><given-names>J</given-names></name>
<name><surname>Meng</surname><given-names>Q</given-names></name>
<name><surname>Guo</surname><given-names>G</given-names></name><etal/>
</person-group>. <article-title>Effects of early enteral nutrition supplemented with arginine on intestinal mucosal immunity in severely burned mice</article-title>. <source>Clin Nutr</source>. <year>2010</year>;<volume>29</volume>:<fpage>124</fpage>-<lpage>130</lpage>.</citation>
</ref>
<ref id="bibr2-0148607112458325">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tan</surname><given-names>B</given-names></name>
<name><surname>Li</surname><given-names>XG</given-names></name>
<name><surname>Kong</surname><given-names>X</given-names></name><etal/>
</person-group>. <article-title>Dietary L-arginine supplementation enhances the immune status in early-weaned piglets</article-title>. <source>Amino Acids</source>. <year>2009</year>;<volume>37</volume>:<fpage>323</fpage>-<lpage>331</lpage>.</citation>
</ref>
<ref id="bibr3-0148607112458325">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>De Jonge</surname><given-names>WJ</given-names></name>
<name><surname>Kwikkers</surname><given-names>KL</given-names></name>
<name><surname>Te Velde</surname><given-names>AA</given-names></name><etal/>
</person-group>. <article-title>Arginine deficiency affects early B cell maturation and lymphoid organ development in transgenic mice</article-title>. <source>J Clin Invest</source>. <year>2002</year>;<volume>110</volume>:<fpage>1539</fpage>-<lpage>1548</lpage>.</citation>
</ref>
<ref id="bibr4-0148607112458325">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sukhotnik</surname><given-names>I</given-names></name>
<name><surname>Mogilner</surname><given-names>J</given-names></name>
<name><surname>Krausz</surname><given-names>MM</given-names></name><etal/>
</person-group>. <article-title>Oral arginine reduces gut mucosal injury caused by lipopolysaccharide in rat</article-title>. <source>J Surg Res</source>. <year>2004</year>;<volume>122</volume>:<fpage>256</fpage>-<lpage>262</lpage>.</citation>
</ref>
<ref id="bibr5-0148607112458325">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ersin</surname><given-names>S</given-names></name>
<name><surname>Tuncyurek</surname><given-names>P</given-names></name>
<name><surname>Esassolak</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>The prophylactic and therapeutic effects of glutamine and arginine enriched diets on radiation induced enteritis in rats</article-title>. <source>J Surg Res</source>. <year>2000</year>;<volume>89</volume>:<fpage>121</fpage>-<lpage>125</lpage>.</citation>
</ref>
<ref id="bibr6-0148607112458325">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gurbuz</surname><given-names>AT</given-names></name>
<name><surname>Kunzelman</surname><given-names>J</given-names></name>
<name><surname>Ratzer</surname><given-names>EE</given-names></name>
</person-group>. <article-title>Supplemental dietary arginine accelerates intestinal mucosal regeneration and enhances bacterial clearance following radiation enteritis in rats</article-title>. <source>J Surg Res</source>. <year>1998</year>;<volume>74</volume>:<fpage>149</fpage>-<lpage>154</lpage>.</citation>
</ref>
<ref id="bibr7-0148607112458325">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Xie</surname><given-names>XQ</given-names></name>
<name><surname>Shinozawa</surname><given-names>Y</given-names></name>
<name><surname>Sasaki</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>The effects of arginine and selective nitric oxide synthase inhibitor on pathophysiology of sepsis in a CLP model</article-title>. <source>J Surg Res</source>. ;<year>2008</year>;<volume>146</volume>:<fpage>298</fpage>-<lpage>303</lpage>.</citation>
</ref>
<ref id="bibr8-0148607112458325">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aktan</surname><given-names>F</given-names></name>
</person-group>. <article-title>iNOS mediated nitric oxide production and its regulation</article-title>. <source>Life Sci</source>. <year>2004</year>;<volume>75</volume>:<fpage>639</fpage>-<lpage>653</lpage>.</citation>
</ref>
<ref id="bibr9-0148607112458325">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kubes</surname><given-names>P</given-names></name>
<name><surname>McCafferty</surname><given-names>DM</given-names></name>
</person-group>. <article-title>Nitric oxide and intestinal inflammation</article-title>. <source>Am J Med</source>. <year>2000</year>;<volume>109</volume>:<fpage>150</fpage>-<lpage>158</lpage>.</citation>
</ref>
<ref id="bibr10-0148607112458325">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Naito</surname><given-names>Y</given-names></name>
<name><surname>Takagi</surname><given-names>T</given-names></name>
<name><surname>Ichikawa</surname><given-names>H</given-names></name><etal/>
</person-group>. <article-title>A novel potent inhibitor of inducible nitric oxide inhibitor, ONO-1714, reduces intestinal ischemia-reperfusion injury in rats</article-title>. <source>Nitric Oxide</source>. <year>2004</year>;<volume>10</volume>:<fpage>170</fpage>-<lpage>177</lpage>.</citation>
</ref>
<ref id="bibr11-0148607112458325">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jia</surname><given-names>YX</given-names></name>
<name><surname>Pan</surname><given-names>CS</given-names></name>
<name><surname>Yang</surname><given-names>JH</given-names></name><etal/>
</person-group>. <article-title>Altered L-arginine/nitric oxide synthase/nitric oxide pathway in the vascular adventitia of rats with sepsis</article-title>. <source>Clin Exp Pharmacol Physiol</source>. <year>2006</year>;<volume>33</volume>:<fpage>1202</fpage>-<lpage>1208</lpage>.</citation>
</ref>
<ref id="bibr12-0148607112458325">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Strunk</surname><given-names>V</given-names></name>
<name><surname>Hahnenkamp</surname><given-names>K</given-names></name>
<name><surname>Schneuing</surname><given-names>M</given-names></name>
<name><surname>Fischer</surname><given-names>LG</given-names></name>
<name><surname>Rich</surname><given-names>GF</given-names></name>
</person-group>. <article-title>Selective iNOS inhibition prevents hypotension in septic rats while preserving endothelium-dependent vasodilatation</article-title>. <source>Anesth Analg</source>. <year>2001</year>;<volume>92</volume>:<fpage>681</fpage>-<lpage>687</lpage>.</citation>
</ref>
<ref id="bibr13-0148607112458325">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Unno</surname><given-names>N</given-names></name>
<name><surname>Wang</surname><given-names>H</given-names></name>
<name><surname>Menconi</surname><given-names>MJ</given-names></name><etal/>
</person-group>. <article-title>Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats</article-title>. <source>Gastroenterology</source>. <year>1997</year>;<volume>113</volume>:<fpage>1246</fpage>-<lpage>1257</lpage>.</citation>
</ref>
<ref id="bibr14-0148607112458325">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hierholzer</surname><given-names>C</given-names></name>
<name><surname>Kalff</surname><given-names>JC</given-names></name>
<name><surname>Billiar</surname><given-names>TR</given-names></name>
<name><surname>Bauer</surname><given-names>AJ</given-names></name>
<name><surname>Tweardy</surname><given-names>DJ</given-names></name>
<name><surname>Harbrecht</surname><given-names>BG</given-names></name>
</person-group>. <article-title>Induced nitric oxide promotes intestinal inflammation following hemorrhagic shock</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2004</year>;<volume>286</volume>: <fpage>G225</fpage>-<lpage>G233</lpage>.</citation>
</ref>
<ref id="bibr15-0148607112458325">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barocelli</surname><given-names>E</given-names></name>
<name><surname>Ballabeni</surname><given-names>V</given-names></name>
<name><surname>Ghizzard</surname><given-names>P</given-names></name><etal/>
</person-group>. <article-title>The selective inhibition of inducible nitric oxide synthase prevents intestinal ischemia-reperfusion injury in mice</article-title>. <source>Nitric Oxide</source>. <year>2006</year>;<volume>14</volume>:<fpage>212</fpage>-<lpage>218</lpage>.</citation>
</ref>
<ref id="bibr16-0148607112458325">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Katada</surname><given-names>K</given-names></name>
<name><surname>Bihari</surname><given-names>A</given-names></name>
<name><surname>Badhwar</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Hindlimb ischemia/reperfusion-induced remote injury to the small intestine: role of inducible nitric-oxide synthase-derived nitric oxide</article-title>. <source>J Pharmacol Exp Ther</source>. <year>2009</year>;<volume>329</volume>:<fpage>919</fpage>-<lpage>927</lpage>.</citation>
</ref>
<ref id="bibr17-0148607112458325">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sasaki</surname><given-names>M</given-names></name>
<name><surname>Bharwani</surname><given-names>S</given-names></name>
<name><surname>Jordan</surname><given-names>P</given-names></name><etal/>
</person-group>. <article-title>Increased disease activity in eNOS-deficient mice in experimental colitis</article-title>. <source>Free Radic Biol Med</source>. <year>2003</year>;<volume>35</volume>: <fpage>1679</fpage>-<lpage>1687</lpage>.</citation>
</ref>
<ref id="bibr18-0148607112458325">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vallance</surname><given-names>BA</given-names></name>
<name><surname>Dijkstra</surname><given-names>G</given-names></name>
<name><surname>Qiu</surname><given-names>B</given-names></name><etal/>
</person-group>. <article-title>Relative contributions of NOS isoforms during experimental colitis: endothelial-derived NOS maintains mucosal integrity</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2004</year>;<volume>287</volume>:<fpage>G865</fpage>-<lpage>G874</lpage>.</citation>
</ref>
<ref id="bibr19-0148607112458325">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dahm</surname><given-names>PL</given-names></name>
<name><surname>Thorne</surname><given-names>J</given-names></name>
<name><surname>Myhre</surname><given-names>E</given-names></name>
<name><surname>Grins</surname><given-names>E</given-names></name>
<name><surname>Martensson</surname><given-names>L</given-names></name>
<name><surname>Blomquist</surname><given-names>S</given-names></name>
</person-group>. <article-title>Intestinal and hepatic perfusion and metabolism in hypodynamic endotoxic shock: effects of nitric oxide synthase inhibition</article-title>. <source>Acta Anaesthesiol Scand</source>. <year>1999</year>;<volume>43</volume>:<fpage>56</fpage>-<lpage>63</lpage>.</citation>
</ref>
<ref id="bibr20-0148607112458325">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Petersson</surname><given-names>J</given-names></name>
<name><surname>Schreiber</surname><given-names>O</given-names></name>
<name><surname>Steege</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>eNOS involved in colitis-induced mucosal blood flow increase</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2007</year>;<volume>293</volume>:<fpage>G1281</fpage>-<lpage>G1287</lpage>.</citation>
</ref>
<ref id="bibr21-0148607112458325">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pedoto</surname><given-names>A</given-names></name>
<name><surname>Tassiopoulos</surname><given-names>A</given-names></name>
<name><surname>Oler</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Treatment of septic shock in rats with nitric oxide synthase inhibitors and inhaled nitric oxide</article-title>. <source>Crit Care Med</source>. <year>1999</year>;<volume>26</volume>:<fpage>2021</fpage>-<lpage>2028</lpage>.</citation>
</ref>
<ref id="bibr22-0148607112458325">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Larquè</surname><given-names>E</given-names></name>
<name><surname>Molina-Sabater</surname><given-names>M</given-names></name>
<name><surname>Zamora</surname><given-names>S</given-names></name>
</person-group>. <article-title>Biological significance of dietary polyamines</article-title>. <source>Nutrition</source>. <year>2007</year>;<volume>23</volume>:<fpage>87</fpage>-<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr23-0148607112458325">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>XP</given-names></name>
<name><surname>Zhang</surname><given-names>J</given-names></name>
<name><surname>Song</surname><given-names>Q</given-names></name>
<name><surname>Chen</surname><given-names>H</given-names></name>
</person-group>. <article-title>Mechanism of acute pancreatitis complication with injury of intestinal barrier</article-title>. <source>J Zhejiang Univ Sci B</source>. <year>2007</year>;<volume>12</volume>:<fpage>888</fpage>-<lpage>895</lpage>.</citation>
</ref>
<ref id="bibr24-0148607112458325">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zaloga</surname><given-names>GP</given-names></name>
<name><surname>Siddiqui</surname><given-names>R</given-names></name>
<name><surname>Terry</surname><given-names>C</given-names></name>
<name><surname>Marik</surname><given-names>PE</given-names></name>
</person-group>. <article-title>Arginine: mediator or modulator of septicemia?</article-title> <source>Nutr Clin Pract</source>. <year>2004</year>;<volume>19</volume>:<fpage>201</fpage>-<lpage>215</lpage>.</citation>
</ref>
<ref id="bibr25-0148607112458325">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Quirino</surname><given-names>IEP</given-names></name>
<name><surname>Correia</surname><given-names>MITD</given-names></name>
<name><surname>Cardoso</surname><given-names>VN</given-names></name>
</person-group>. <article-title>The impact of arginine on bacterial translocation in an intestinal obstruction model in rats</article-title>. <source>Clin Nutr</source>. <year>2007</year>;<volume>26</volume>:<fpage>335</fpage>-<lpage>3450</lpage>.</citation>
</ref>
<ref id="bibr26-0148607112458325">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jorgensen</surname><given-names>VL</given-names></name>
<name><surname>Nielsen</surname><given-names>SL</given-names></name>
<name><surname>Espersen</surname><given-names>K</given-names></name>
<name><surname>Perner</surname><given-names>A</given-names></name>
</person-group>. <article-title>Increased colorectal permeability in patients with severe sepsis and septic shock</article-title>. <source>Intensive Care Med</source>. <year>2006</year>;<volume>32</volume>:<fpage>1790</fpage>-<lpage>1796</lpage>.</citation>
</ref>
<ref id="bibr27-0148607112458325">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Batista</surname><given-names>MA</given-names></name>
<name><surname>Nicoli</surname><given-names>J</given-names></name>
<name><surname>Martins</surname><given-names>FS</given-names></name><etal/>
</person-group>. <article-title>Pretreatment with citrulline improves gut barrier after intestinal obstruction in mice</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2012</year>;<volume>36</volume>:<fpage>69</fpage>-<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr28-0148607112458325">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Santos</surname><given-names>RGC</given-names></name>
<name><surname>Viana</surname><given-names>ML</given-names></name>
<name><surname>Generoso</surname><given-names>SV</given-names></name>
<name><surname>Arantes</surname><given-names>RME</given-names></name>
<name><surname>Correia</surname><given-names>MITD</given-names></name>
<name><surname>Cardoso</surname><given-names>VN</given-names></name>
</person-group>. <article-title>Glutamine supplementation decreases intestinal permeability and preserves gut mucosa integrity in an experimental mouse model</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2010</year>;<volume>34</volume>:<fpage>408</fpage>-<lpage>413</lpage>.</citation>
</ref>
<ref id="bibr29-0148607112458325">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vale</surname><given-names>SR</given-names></name>
<name><surname>Glória</surname><given-names>MB</given-names></name>
</person-group>. <article-title>Determination of biogenic amines in cheese</article-title>. <source>J AOAC Int</source>. <year>1997</year>;<volume>80</volume>:<fpage>1006</fpage>-<lpage>1012</lpage>.</citation>
</ref>
<ref id="bibr30-0148607112458325">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kalil</surname><given-names>AC</given-names></name>
<name><surname>Danner</surname><given-names>RL</given-names></name>
</person-group>. <article-title>L-arginine supplementation in sepsis: beneficial or harmful?</article-title> <source>Curr Opin Crit Care</source>. <year>2006</year>;<volume>12</volume>:<fpage>303</fpage>-<lpage>308</lpage>.</citation>
</ref>
<ref id="bibr31-0148607112458325">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Xie</surname><given-names>XQ</given-names></name>
<name><surname>Shinozawa</surname><given-names>Y</given-names></name>
<name><surname>Sasaki</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>The effects of ;arginine ;and selective inducible nitric oxide synthase inhibitor on pathophysiology of sepsis in a CLP model</article-title>. <source>J Surg Res</source>. <year>2008</year>;<volume>146</volume>:<fpage>298</fpage>-<lpage>303</lpage>.</citation>
</ref>
<ref id="bibr32-0148607112458325">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Balzan</surname><given-names>S</given-names></name>
<name><surname>Quadros</surname><given-names>CA</given-names></name>
<name><surname>Cleva</surname><given-names>R</given-names></name>
<name><surname>Ziberstein</surname><given-names>B</given-names></name>
<name><surname>Cecconelo</surname><given-names>I</given-names></name>
</person-group>. <article-title>Bacterial translocation: overview of mechanisms and clinical impact</article-title>. <source>J Gastroenterol Hepatol</source>. ;<year>2007</year>;<volume>22</volume>:<fpage>464</fpage>-<lpage>471</lpage>.</citation>
</ref>
<ref id="bibr33-0148607112458325">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thomas</surname><given-names>S</given-names></name>
<name><surname>Ramachandran</surname><given-names>A</given-names></name>
<name><surname>Patra</surname><given-names>S</given-names></name>
<name><surname>Vidyasagar</surname><given-names>S</given-names></name>
<name><surname>Balasubramanian</surname><given-names>A</given-names></name>
</person-group>. <article-title>Nitric oxide protects the intestine from the damage induced by laparotomy and gut manipulation</article-title>. <source>J Surg Res</source>. <year>2001</year>;<volume>99</volume>:<fpage>25</fpage>-<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr34-0148607112458325">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Porras</surname><given-names>M</given-names></name>
<name><surname>Martin</surname><given-names>MT</given-names></name>
<name><surname>Yang</surname><given-names>PC</given-names></name>
<name><surname>Jury</surname><given-names>J</given-names></name>
<name><surname>Perdue</surname><given-names>MH</given-names></name>
<name><surname>Vergara</surname><given-names>P</given-names></name>
</person-group>. <article-title>Correlation between cyclical epithelial barrier dysfunction on bacterial translocation in the relapses of intestinal inflammation</article-title>. <source>Inflamm Bowel Dis</source>. <year>2006</year>;<volume>18</volume>: <fpage>843</fpage>-<lpage>852</lpage>.</citation>
</ref>
<ref id="bibr35-0148607112458325">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hierholzer</surname><given-names>C</given-names></name>
<name><surname>Kalff</surname><given-names>JC</given-names></name>
<name><surname>Billiar</surname><given-names>TR</given-names></name>
<name><surname>Bauer</surname><given-names>AJ</given-names></name>
<name><surname>Tweardy</surname><given-names>DJ</given-names></name>
<name><surname>Harbrecht</surname><given-names>B</given-names></name>
</person-group>. <article-title>Induced nitric oxide promotes intestinal inflammation following hemorrhagic shock</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2003</year>;<volume>286</volume>: <fpage>G226</fpage>-<lpage>G233</lpage>.</citation>
</ref>
<ref id="bibr36-0148607112458325">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hardy</surname><given-names>I</given-names></name>
<name><surname>Alany</surname><given-names>R</given-names></name>
<name><surname>Russel</surname><given-names>B</given-names></name>
<name><surname>Hardy</surname><given-names>G</given-names></name>
</person-group>. <article-title>Antimicrobial effects of arginine and nitrogen oxides and their potential role in septicemia</article-title>. <source>Curr Opin Clin Nutr Metab Care</source>. <year>2006</year>;<volume>9</volume>:<fpage>222</fpage>-<lpage>232</lpage>.</citation>
</ref>
<ref id="bibr37-0148607112458325">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shang</surname><given-names>HF</given-names></name>
<name><surname>Wang</surname><given-names>YY</given-names></name>
<name><surname>Lai</surname><given-names>YN</given-names></name>
<name><surname>Chiu</surname><given-names>WC</given-names></name>
<name><surname>Yeh</surname><given-names>SL</given-names></name>
</person-group>. <article-title>Effects of arginine supplementation on mucosal immunity in rats with septic peritonitis</article-title>. <source>Clin Nutr</source>. <year>2004</year>;<volume>23</volume>:<fpage>561</fpage>-<lpage>569</lpage>.</citation>
</ref>
<ref id="bibr38-0148607112458325">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sukhotnik</surname><given-names>I</given-names></name>
<name><surname>Mogilner</surname><given-names>J</given-names></name>
<name><surname>Krausz</surname><given-names>MM</given-names></name>
<name><surname>Lurie</surname><given-names>M</given-names></name>
<name><surname>Hirsh</surname><given-names>M</given-names></name>
<name><surname>Coran</surname><given-names>AG</given-names></name>
</person-group>. <article-title>Oral arginine reduces gut mucosal injury caused by lipopolysaccharide in rat</article-title>. <source>J Sur Res</source>. <year>2004</year>;<volume>122</volume>:<fpage>256</fpage>-<lpage>262</lpage>.</citation>
</ref>
<ref id="bibr39-0148607112458325">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Viana</surname><given-names>ML</given-names></name>
<name><surname>Santos</surname><given-names>RGC</given-names></name>
<name><surname>Generoso</surname><given-names>SV</given-names></name>
<name><surname>Arantes</surname><given-names>RME</given-names></name>
<name><surname>Correia</surname><given-names>MITD</given-names></name>
<name><surname>Cardoso</surname><given-names>VN</given-names></name>
</person-group>. <article-title>Pretreatment with arginine preserves intestinal barrier integrity and reduces bacterial translocation in mice</article-title>. <source>Nutrition</source>. <year>2010</year>;<volume>26</volume>:<fpage>218</fpage>-<lpage>223</lpage>.</citation>
</ref>
<ref id="bibr40-0148607112458325">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Osaowska</surname><given-names>S</given-names></name>
<name><surname>Neveux</surname><given-names>N</given-names></name>
<name><surname>Nakib</surname><given-names>S</given-names></name>
<name><surname>Lasserre</surname><given-names>V</given-names></name>
<name><surname>Cynober</surname><given-names>L</given-names></name>
<name><surname>Moinard</surname><given-names>C</given-names></name>
</person-group>. <article-title>Impairment of arginine metabolism in rats after massive intestinal resection: effect of parenteral nutrition supplemented nutrition with citrulline compared with arginine</article-title>. <source>Clin Sci</source>. <year>2008</year>;<volume>115</volume>:<fpage>159</fpage>-<lpage>166</lpage>.</citation>
</ref>
<ref id="bibr41-0148607112458325">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gobert</surname><given-names>AP</given-names></name>
<name><surname>Cheng</surname><given-names>Y</given-names></name>
<name><surname>Akhtar</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Protective role of arginase in a mouse model of colitis</article-title>. <source>J Immunol</source>. <year>2004</year>;<volume>173</volume>:<fpage>2109</fpage>-<lpage>2117</lpage>.</citation>
</ref>
<ref id="bibr42-0148607112458325">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>G</given-names></name>
<name><surname>Bazer</surname><given-names>FW</given-names></name>
<name><surname>Davis</surname><given-names>TA</given-names></name><etal/>
</person-group>. <article-title>Arginine metabolism and nutrition in growth, health and disease</article-title>. <source>Amino Acids</source>. <year>2009</year>;<volume>37</volume>:<fpage>153</fpage>-<lpage>168</lpage>.</citation>
</ref>
<ref id="bibr43-0148607112458325">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moinard</surname><given-names>C</given-names></name>
<name><surname>Cynober</surname><given-names>L</given-names></name>
<name><surname>De Bandt</surname><given-names>JP</given-names></name>
</person-group>. <article-title>Polyamines: metabolism and implications in human diseases</article-title>. <source>Clin Nutr</source>. <year>2005</year>;<volume>24</volume>:<fpage>184</fpage>-<lpage>197</lpage>.</citation>
</ref>
<ref id="bibr44-0148607112458325">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Czernichow</surname><given-names>B</given-names></name>
<name><surname>Nsi-Emvo</surname><given-names>E</given-names></name>
<name><surname>Galluser</surname><given-names>M</given-names></name>
<name><surname>Gosse</surname><given-names>M</given-names></name>
<name><surname>Raul</surname><given-names>F</given-names></name>
</person-group>. <article-title>Enteral supplementation with ornithine alpha ketoglutarate improves the early adaptive response to resection</article-title>. <source>Gut</source>. <year>1997</year>;<volume>40</volume>:<fpage>67</fpage>-<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr45-0148607112458325">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Noguchi</surname><given-names>Y</given-names></name>
<name><surname>Meyer</surname><given-names>TA</given-names></name>
<name><surname>Tiao</surname><given-names>G</given-names></name>
<name><surname>Fischer</surname><given-names>JE</given-names></name>
<name><surname>Hasselgren</surname><given-names>PO</given-names></name>
</person-group>. <article-title>Influence of septicemia and endotoxemia on polyamines metabolism in mucosa of small intestine in rats</article-title>. <source>Metabolism</source>. <year>1996</year>;<volume>45</volume>:<fpage>28</fpage>-<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr46-0148607112458325">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Duranton</surname><given-names>B</given-names></name>
<name><surname>Schleiffer</surname><given-names>R</given-names></name>
<name><surname>Gosse</surname><given-names>F</given-names></name>
<name><surname>Raul</surname><given-names>F</given-names></name>
</person-group>. <article-title>Preventive administration of ornithine alpha-ketoglutarate improves mucosal repair after transient ischemia in rats</article-title>. <source>Crit Care Med</source>. <year>1998</year>;<volume>26</volume>:<fpage>120</fpage>-<lpage>125</lpage>.</citation>
</ref>
<ref id="bibr47-0148607112458325">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ochoa</surname><given-names>JB</given-names></name>
<name><surname>Makarenkova</surname><given-names>V</given-names></name>
<name><surname>Bansal</surname><given-names>V</given-names></name>
</person-group>. <article-title>A rational use of immune enhancing diets: when should we use dietary arginine supplementation?</article-title> <source>Nutr Clin Pract</source>. <year>2004</year>;<volume>19</volume>:<fpage>216</fpage>-<lpage>225</lpage>.</citation>
</ref>
<ref id="bibr48-0148607112458325">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Morris</surname><given-names>SM</given-names><suffix>Jr</suffix></name>
</person-group>. <article-title>Arginine: master and commander in innate immune responses</article-title>. <source>Sci Signal</source>. <year>2010</year>;<volume>3</volume>:<fpage>27</fpage>-<lpage>31</lpage>.</citation>
</ref></ref-list>
</back>
</article>